Overall conference learning sessions
By the end of this conference, participants will be able to:

1. Identify current research regarding the affects of prenatal alcohol exposure (PAE) and the support of individuals with Fetal Alcohol Spectrum Disorder (FASD)
2. Describe evidence-based treatment and supports for individuals and families living with FASD
3. Recognize the lived experiences of people living with FASD to inform clinical and research practices
4. Plan community networking and collaboration opportunities by bringing together basic scientists, clinicians and those with lived experience

Session specific learning objectives, are as follows:
By the end of these presentations, participants will be able to:

James Reynolds (keynote speaker)
Prenatal Alcohol Exposure: Building a picture of the brain-behaviour relationship

1. Describe the relationship between structural and functional brain injury related to prenatal alcohol exposure and neurobehavioural deficits in children.
2. Describe the potential use of biomarkers as predictors of prenatal alcohol exposure and clinical outcomes.
3. Describe the contribution of the postnatal environment in determining long-term outcomes for children impacted by prenatal alcohol exposure.

Dr. Jean M Clinton (keynote speaker)
Building Healthy Brains – the Way Forward

1. Identify the interplay between childhood experiences, trauma & prenatal alcohol exposure & neuroplasticity.
2. Identify ways to support the developing brain.
3. Explain regulation & co-regulation.

Dr. Katherine Willmore and Dr. Daniel Hardy
The impact of prenatal alcohol and/or cannabis on postnatal health outcomes: are there common links?

1. Recognize the latest clinical data examining the perceptions of alcohol and cannabis use in pregnancy, and the effects on maternal-fetal outcomes.
2. Identify, using the outcomes of an anumal model, the effects of maternal age and periconceptional ethanol exposure in pregnancy on maternal-fetal outcomes and keletal craniofacial features.
3. Identify, using the outcomes of an animal model, the effects of 9-THC and/or CBD exposure in pregnancy on maternal-fetal outcomes and long-term metabolic outcomes.
4. Describe the effects of cannabinoid exposure on neurobehavioural outcomes.

Kaitlyn McLachlan and Officer Brenna Bonn

FASD and The Law

1. Describe up-to-date Canadian and international research about FASD in the criminal justice system.
2. Identify common points of difficulty and emerging best practice for individuals with FASD and

professionals working within the justice system.

3. Identify the program objectives, goals, development, and execution of Reach for IT, a novel recreational program for children and families with FASD, with relevance to justice professionals.

Dilys Haner and Robyn Brady
Adding FASD informed approaches into your practice

1. Identify the unique needs of clients and families touched by FASD.
2. Identify areas of their own practice that are already FASD-informed.
3. Use the neurodevelopmental lens to their practice procedures, and determine which of the FASD-informed practices presented can be implemented into their own work.

Nancy Lockwood, Darlene Donnelly and Tanya
Self-Advocacy

1. Identify common challenges and barriers facing adults with FASD and their families.
2. Analyze the need for adults with FASD and their families to develop advocacy skills in order to make a lifetime plan for the individual with FASD.
3. Develop an introduction of strategies, including outside-the-box ideas, for developing a safe and secure future for adults with FASD.

Mo Oshalla
Understanding speech and language difficulties in FASD

1. Explain the role of the SLP in the FASD diagnostic process.
2. Identify the specific cognitive, linguistic, and cognitive-linguistic variables examined by the SLP.
3. Analyze how the information derived from examination is interpreted within the FASD lens.

Dr Michael Rieder (keynote speaker)
Cannabinoids and FASD

1. Describe the mechanisms of action of cannabinoids.
2. Analyze the potential benefits and risks of cannabinoids for selected neurological conditions in childhood and analyze how this may or may not apply to the therapy of children with FASD.
3. Examine the partical issues in prescribing cannabinoids to children.
4. Discuss with parents the potential risks, benefits and indications for medical cannabinoids in children with special reference to FASD.

Mansfield Mela and Dr. Ana Hanlon
Medication Use in FASD

1. Review current state of evidence for treatment of symptoms in FASD
2. Define the development of the medication algorithm for FASD
3. Analyze clinical approaches to managing complex symptoms in FASD

Dr. Choate, Angela Geddes
Doing things differently – Stigma and the ‘missed ones’ 

1. Describe how people affected by PAE/FASD are stigmatized.
2. Employ for the advocacy of assessment, diagnostic and support services based upon knowledge of trauma, and the warning signs of probable pre-natal alcohol exposure.
3. Recall an intersectional map of needs to create a more relevant and inclusive service plan.

Dr. Shapiro and Rabiya Fahmi
Sleep challenges and FASD 

1. Analyze the impact FASD on a child’s sleep.
2. Recognize the impact of abnormal melatonin secretion on sleep and how children with FASD have damage to their suprachiasmatic nucleus.
3. Explain the necessity of good sleep, and how FASD impacts not only the child’s sleep but also the caretakers. In turn, it ends up affecting the entire household and daily functioning.

 

Register Now!

Contact

Education & Learning Services, CPRI 
CPRI Education 
519-858-2774 x2159

Text: 519-200-0317

Email: cpri.educate@ontario.ca 

Disclaimer

The views and opinions expressed by presenters do not necessarily state or reflect those of MCCSS/CPRI. MCCSS/CPRI does not promote, endorse, or recommend any specific products, processes, or services.